Thymulin

Thymic peptide hormones (thymosin, thymulin, thymopoietin) circulate to impact peripheral immune cells and tumor biology.; Intrathymic T cell differentiation is regulated by stromal cell-derived hormones and cytokines.; Manipulating the thymic microenvironment may improve cancer treatment responses and reduce adverse effects.; Evidence from clinical and preclinical studies shows complex immunoendocrine interactions in anti-tumor immunity.

Thymic peptides have two known categories of effects: influence on immune cells and interconnection with neuroendocrine systems.; A third, previously unclear aspect involves intranuclear precursors of thymic peptides that are ubiquitous and highly abundant in all somatic cells.; Under stress-related conditions, these precursors are cleaved to form immunologically active peptides that leave the nucleus and intracellular spaces.; These peptides act as 'distress signals' to the immune system, functioning as stress sensors and potentially linking somatic cells to immune and neuroendocrine systems.

In the first 2 weeks of booster immunization, thymulin was repressed when reproductive hormones were severely reduced.; Later immune stages showed rising circulating thymulin that upregulated LH, FSH, and hypothalamic GnRH, though levels remained lower than controls.; Thymulin produced a feedback effect on GnRH neurons in astrocytes, while in the arcuate nucleus and median eminence, glial cells were directly affected by reproductive hormones.; Immunization against GnRH distinctly stimulated glial fibrillary acidic protein expression in the arcuate nucleus and median eminence.

Thymulin production and secretion are strongly influenced by the neuroendocrine system.; Thymulin and its synthetic analog exhibit anti-inflammatory and analgesic effects in the central nervous system and other organs.; Gene therapy with a bidirectional Tet-Off vector expressing metFTS can prevent hormonal and reproductive abnormalities in congenitally athymic mice.; Novel biotechnological tools may enable restoration of circulating thymulin levels in thymodeficient models and potentially humans.

Adenoviral vector with synthetic thymulin gene restored normal thymulin levels for months in thymectomized and nude mice/rats.; Thymulin gene therapy in nude mice prevented post-pubertal pituitary and ovarian alterations.; Neonatal thymulin gene therapy prevented lipid metabolism abnormalities in congenitally athymic mice.; Adenovirally-delivered thymulin showed longer brain expression than reporter genes, consistent with its antiinflammatory activity.

Zinc deficiency decreases serum thymulin activity and T-helper 1 cytokines, leading to cell-mediated immune dysfunction.; Zinc deficiency reduces NF-kappaB activation and DNA binding, decreasing Th1 cytokine production in cell culture.; Zinc supplementation in humans lowers pro-inflammatory cytokine gene expression and oxidative stress markers.; In HL-60 cells, zinc induces A20, which inhibits NF-kappaB and reduces pro-inflammatory cytokines.

What is Thymulin?

**Mechanism of Action** Thymulin (Facteur Thymique Serique, FTS) is a zinc-dependent nonapeptide secreted by thymic epithelial cells. Its biological activity requires chelation of zinc ions, which stabilizes its conformation for binding to high-affinity receptors on T-cell precursors and mature lymphocytes. Thymulin pr

How does Thymulin work?

Zinc-dependent thymic nonapeptide that regulates T-cell differentiation and has analgesic and anti-inflammatory effects.

What is the research status of Thymulin?

Thymulin is currently classified as preclinical, with 374 research references on record. This is for research purposes only and is not medical advice.

What is the molecular weight of Thymulin?

Thymulin has a molecular weight of approximately 858.9 g/mol (formula C33H54N12O15).